A focus on the practical: how can cardiologists best utilise GLP-1RAs in the clinic?

27 August 2023 (13:25 - 13:33)

Organised by:

About the speaker

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)

5 More presentations in this session

Presentation thumbnail

Welcome and introductions: cardiovascular risk in people with type 2 diabetes and/or obesity

Professor N. Marx (Aachen, DE)

Presentation thumbnail

The effect of GLP-1RAs on cardiovascular disease and cardio-metabolic risk factors in patients with obesity and/or type 2 diabetes

Professor S. Verma (Toronto, CA)

Presentation thumbnail

GLP-1RAs: what does the future hold?

Doctor T. Vilsboll (Copenhagen, DK)

Presentation thumbnail

Panel discussion and Q&A

Presentation thumbnail

Closing

Professor N. Marx (Aachen, DE)

Access the full session

Session thumbnail

A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future

The Event

Event poster

ESC Congress 2023

27 August 2023 13:25 CET

You may be interested in

Congress Presentation

Practical considerations for the use of GLP-1 RAs in the clinic.

28 August 2022

Congress Presentation

Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment

3 September 2019

Webinar

GLP-1 RAs and HFpEF : what do we know from large RCTs about GLP-1 RAs and their effects on HFpEF?

24 November 2025

Congress Presentation

Exploring the preventive role of GLP-1 receptor agonists in reducing pulmonary hypertension in diabetes: a multimodal analysis

3 April 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources